A phase I trial of perillyl alcohol administered four times daily for 14 days out of 28 days

Author： Bailey Howard   Wilding George   Tutsch Kendra   Arzoomanian Rhoda   Alberti Dona   Feierabend Chris   Simon Kris   Marnocha Rebecca   Holstein Sarah   Stewart Jan   Lewis Kriste   Hohl Raymond  

Publisher： Springer Publishing Company

ISSN： 0344-5704

Source： Cancer Chemotherapy and Pharmacology, Vol.54, Iss.4, 2004-10, pp. : 368-376

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Final results of a phase I and pharmacokinetic study of γ-methylene-10-deazaaminopterin (MDAM) administered intravenously daily for five consecutive days in patients with solid tumors

By Johansen Mary   Zukowski Thomas   Hoff Paulo   Newman Robert   Ni Dan   Hutto Toni   Abbruzzeese James   Berghorn Elmer   Hausheer Frederick   Madden Timothy  

Cancer Chemotherapy and Pharmacology, Vol. 53, Iss. 5, 2004-05 ,pp. : 370-376

Springer Publishing Company

Access to resources Recommend Favorite

Phase II trial of daily oral perillyl alcohol (NSC 641066) in treatment-refractory metastatic breast cancer

By Bailey Howard   Attia Steven   Love Richard   Fass Terri   Chappell Rick   Tutsch Kendra   Harris Linda   Jumonville Alcee   Hansen Richard   Shapiro Gary   Stewart James  

Cancer Chemotherapy and Pharmacology, Vol. 62, Iss. 1, 2008-06 ,pp. : 149-157

Springer Publishing Company

Access to resources Recommend Favorite

Phase I and pharmacokinetic study of S-1 administered for 14 days in a 21-day cycle in patients with advanced upper gastrointestinal cancer

By Zhu Andrew   Clark Jeffrey   Ryan David   Meyerhardt Jeffrey   Enzinger Peter   Earle Craig   Fuchs Charles   Regan Eileen   Anbe Hiroshi   Houghton Michele   Zhang Joshua   Urrea Peter   Kulke Matthew  

Cancer Chemotherapy and Pharmacology, Vol. 59, Iss. 3, 2007-03 ,pp. : 285-293

Springer Publishing Company

Access to resources Recommend Favorite

A Phase II Trial of Daily Perillyl Alcohol in Patients with Advanced Ovarian Cancer: Eastern Cooperative Oncology Group Study E2E96

By Bailey H.H.   Levy D.   Harris L.S.   Schink J.C.   Foss F.   Beatty P.   Wadler S.  

Gynecologic Oncology, Vol. 85, Iss. 3, 2002-06 ,pp. : 464-468

Academic Press

Access to resources Recommend Favorite

Phase II trial of perillyl alcohol in patients with metastatic colorectal cancer

By Meadows Sherry   Mulkerin Daniel   Berlin Jordan   Bailey Howard   Kolesar Jill   Warren Deb   Thomas James  

International Journal of Gastrointestinal Cancer, Vol. 32, Iss. 2-3, 2002-12 ,pp. : 125-128

Humana Press, Inc

Access to resources Recommend Favorite